Member Info for Fireblade23

Also An extended well test at site will enable us to confirm commercial flow rates and fluid composition, whilst continuing to plan for development and production scenarios in parallel.”

News will be released thick and fast over the coming weeks

Updates on “Helium One also revealed it’s starting talks with potential vendors for production facility engineering.”

for instance, and will push the price back over 2p in short order.

Excellent

1.5p was the last fund raise discounted price, looking like the bottom, I suggest we may settle around the 1.65/70 level this afternoon, some strong buying still at 1.5+

This is, and will continue to be a great trading share, with little risk long term as it’s going to hit 20p at some point in time.

I bought yesterday at 1.77 and sold a 2.03, I’ve just loaded again at 1.54, so we will see how it goes.

Here we go 2.3p easy finish today

In the long term this has got to be the best long term holds on Aim at these levels

Recovery starting, stop losses caught out buying back, this should be 3p with that RNS

It’s just knocked out a load of stop losses, rebound incoming as investors scramble to get back in

The spread is just 12% now, 0.49 to sell 0.55 to buy

£7 million raised in November, they must still have most of that!!! Market cap looks super cheap

Well worth a punt on Monday, They raised £7m less than 3 months ago at 17p a share , this could do 2p next week, market cap now just £1.5m. This company had a market cap of over £100 million last year.

Https://future-metals.com.au/investor-centre/media/latest-video/

This investment could be huge over the next five years, one for my long term pension pot, especially if PGM prices rise as expected.

Just spotted another £84k buy at 2.82 just before close.

Date Time Trade Prc Volume Buy/Sell Value

21-Feb-24 16:24:37 2.825 3,000,000 84.75k

I expect we will see another Rns in the next few days, I am sure the insider’s will be busy buying again at these prices.

London, UK, 27 November 2023: Shield Therapeutics plc

(LSE:STX), a commercial stage pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol), confirms that Mr Hans Peter Hasler, Chairman, acquired 2,000,000 Ordinary Shares in the Company on 21 November 2023 at a price of 6.1p per share. Mr Hasler now holds a beneficial interest in 5,500,000 Ordinary Shares.

£67k buy at 16:35, and a £83k late reported buy from 14.45 @(2.78) it had to be a buy because the sell price was around 2.73 @ 14:45.

Looking good for tomorrow.

Stop losses will have been triggered for most of the drop this morning, at this level with the massive increase in revenues it’s a strong buy in my opinion.

I am expecting to finish the day around 3.65

Loaded at 2.85 just waiting for rebound now, looks way oversold looking at revenues

Now fully funded at 1.6, hopefully we should start getting some updates and some interest in FME.